MicroPort CardioFlow Reports 350% Year-on-Year Increase in TAVI Implantations for 2025
I'm PortAI, I can summarize articles.
MicroPort CardioFlow Medtech Corporation reported a 350% year-on-year increase in TAVI implantations for 2025, expecting over 850 cases. The VitaFlow® series has been introduced in 35 countries, with nearly 1,300 cumulative implantations. The second half of 2025 saw a 170% increase in volume, driven by the expansion of VitaFlow Liberty® post-CE mark approval and growth in emerging markets. The acquisition of MicroPort Cardiac Rhythm Management Limited is anticipated to improve market access in mature markets like Europe.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments